Controlled hypertension and life insurance premiums

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.

American heart journal·1999

Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Drug safety·1996

Beyond controlling blood pressure in the black patient: metabolic considerations.

Journal of the National Medical Association·1995

The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.

Journal of clinical pharmacology·1995

First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.

Journal of clinical pharmacology·1995

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.

Archives of internal medicine·1994

Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial.

JAMA·2026

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

JAMA·2026

Coevolutionary vaccination dynamics driven by committed influencers on complex networks.

Chaos (Woodbury, N.Y.)·2026

Quantifying Influence: The Orthopaedic PAC's Impact Explored Through Analysis of FEC Data.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2026

Institutionalizing family care responsibility in China's multilevel medical security system: evidence from long-term care insurance policy texts through a Confucian care ethics lens.

Frontiers in public health·2026

Governance and planning gaps in sugar-sweetened beverage taxation: A systems-based public health analysis.

Public health·2026

Are commercial determinants of health addressed in Australian health policies?

Health promotion international·2026

Determinants of Implementing the 2024 Weight Management Guidelines in Overweight Patients with Coronary Heart Disease in China: A CFIR-Based Qualitative Study of Patient and Caregiver.

Journal of multidisciplinary healthcare·2026

Related Experiment Videos

Controlled hypertension and life insurance premiums

Related Concept Videos

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.

Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Beyond controlling blood pressure in the black patient: metabolic considerations.

The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.

First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.

Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial.

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

Coevolutionary vaccination dynamics driven by committed influencers on complex networks.

Quantifying Influence: The Orthopaedic PAC's Impact Explored Through Analysis of FEC Data.

Institutionalizing family care responsibility in China's multilevel medical security system: evidence from long-term care insurance policy texts through a Confucian care ethics lens.

Governance and planning gaps in sugar-sweetened beverage taxation: A systems-based public health analysis.

Are commercial determinants of health addressed in Australian health policies?

Determinants of Implementing the 2024 Weight Management Guidelines in Overweight Patients with Coronary Heart Disease in China: A CFIR-Based Qualitative Study of Patient and Caregiver.

Related Experiment Videos

Controlled hypertension and life insurance premiums

Related Concept Videos

Related Articles